---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-013061"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2026-01-14T23:59:59+00:00"
generated_at: "2026-05-16T10:22:54.938281+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Emergent BioSolutions CEO presents at J.P. Morgan Healthcare Conference; no new data

## Summary
- CEO Joe Papa presented at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.
- Investor slides furnished as Exhibit 99.1 contain no specific financial results or guidance updates.
- No material business or operational changes disclosed in the filing or exhibit.

## SEC filing metadata
- accession: 0001193125-26-013061
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2026-01-14T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/0001193125-26-013061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000119312526013061/d921176d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-013061
- JSON: https://secwatch.observer/filing/0001193125-26-013061.json
- Plain text: https://secwatch.observer/filing/0001193125-26-013061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.